Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Breast Cancer Research and Treatment|July 10, 2025
Immediate and ipsilateral recurrence rates and treatment recommendations for patients with pleomorphic and florid lobular carcinoma in situLavinia P Middleton, George H Perkins, Gary J Whitman, et al.
NPJ Breast Cancer|February 9, 2026
Prevalence of HER2-low status and outcomes in early-stage HER2-negative breast cancerAkshara Singareeka Raghavendra, Diane D Liu, Sarah Pasyar, et al.
Cancers|January 28, 2026
Prevalence and Outcomes of HER2-Low Versus HER2-0 Status in Patients with Metastatic Breast CancerAkshara Singareeka Raghavendra, Diane D Liu, Senthil Damodaran, et al.
Journal of Clinical and Translational Science|October 13, 2023
Erratum: 53 The development of a multi-institutional prospective registry for patients with metastatic invasive lobular carcinoma: identifying new markers of disease progression - CORRIGENDUMHarriet T Rothschild, A Jo Chien, Rachel C Jankowitz, et al.
Cancer Medicine|June 3, 2021
Lumpectomy followed by radiation improves survival in HER2 positive and triple-negative breast cancer with high tumor-infiltrating lymphocytes compared to mastectomy aloneJason A Mouabbi, Momal Chand, Ishaq A Asghar, et al.
European Journal of Cancer (Oxford, England : 1990)|August 13, 2023
Absence of lobular carcinoma in situ is a poor prognostic marker in invasive lobular carcinomaJason A Mouabbi, Akshara Singareeka Raghavendra, Roland L Bassett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2025
Human Epidermal Growth Factor Receptor 2 Loss following Treatment with Trastuzumab Deruxtecan in Patients with Metastatic Breast CancerMohamed A Gouda, Amrit Gonugunta, Ecaterina E Dumbrava, et al.
International Journal of Radiation Oncology, Biology, Physics|July 20, 2025
Limitations in the Application of Clinicopathologic Factors Alone in Predicting Radiation Benefit for Women With Low-Risk Ductal Carcinoma In Situ After Breast Conserving Surgery: The Impact of a 7-Gene Biosignature Based on 10-Year Ipsilateral Breast Recurrence RatesFrank Vicini, Chirag Shah, Karuna Mittal, et al.
Pageof 2